New Zealand clears first clinical trial of epigenetic editing for hepatitis B - Endpoints News

New Zealand approved Tune Therapeutics' TUNE-401, an epigenetic editing therapy for chronic hepatitis B, for human trials. Led by Ed Gane at Auckland City Hospital, it's the second HBV genome-altering therapy to enter trials after Precision Biosciences' t

Ads Links by Easy Branches
Play online games for free at games.easybranches.com

Guest Post Services www.easybranches.com/contribute
Smart Social Media Use Reduces Teen Stress - Neuroscience News
Golden Retriever Friends' Sweet Reunion After a Year Apart Gives Hallmark Movie Vibes - Yahoo Life

The Underrated Bread That Can Lower Cholesterol And Blood Sugar At The Same Time - Health Digest
Epidemic of sexually transmitted infections slows, CDC says, but some still trending upward in New York state, LI - Newsday